Low-Dose Treatment with Erythropoiesis-Stimulating Agents and Cardiovascular Geometry in Chronic Kidney Disease: Is Darbepoetin-α More Effective than Expected?

INTRODUCTION: Chronic kidney disease (CKD) is a widespread invalidating condition, leading to erythropoietin deficiency and decreased cardiovascular performance. Darbepoetin-α and epoetin-α are extensively used to correct renal anemia. The aim of this study was to evaluate cardiological outcomes in...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Di Lullo, Luca, Floccari, Fulvio, Granata, Antonio, Malaguti, Moreno
Formato: Artigo
Lenguaje:Inglês
Publicado: S. Karger AG 2012
Materias:
Original Paper
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3318933/
https://ncbi.nlm.nih.gov/pubmed/22493599
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000334942
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares